Market Tracker

02/10 3:08pm ET

Galena Biopharma Inc (NASDAQ:GALE)

0.7299
Delayed Data
As of 2:52pm ET
 +0.0588 / +8.76%
Today’s Change
0.59
Today|||52-Week Range
2.39
-50.35%
Year-to-Date
No recent news for Galena Biopharma Inc.

Today’s Trading

Previous close0.67
Today’s open0.66
Day’s range0.65 - 0.75
Volume1,315,776
Average volume (3 months)1,373,990
Market cap$121.9M
Dividend yield--
Data as of 2:52pm ET, 02/10/2016

Growth & Valuation

Earnings growth (last year)+63.53%
Earnings growth (this year)+3.87%
Earnings growth (next 5 years)--
Revenue growth (last year)+274.71%
P/E ratioNM
Price/Sales19.35
Price/Book2.34

Competitors

 Today’s
change
Today’s
% change
DRRXDURECT Corp+0.01+0.99%
DRNADicerna Pharmaceutic...-0.24-4.05%
ECYTEndocyte Inc+0.07+2.40%
TBRATobira Therapeutics ...+0.49+7.48%
Data as of 3:05pm ET, 02/10/2016

Financials

Next reporting dateMarch 23, 2016
EPS forecast (this quarter)-$0.06
Annual revenue (last year)$9.3M
Annual profit (last year)-$36.6M
Net profit margin-392.81%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Mark W. Schwartz
Senior VP-Clinical Sciences &
Operations
Gavin S. Choy
Corporate headquarters
Portland, Oregon

Forecasts